Bath & Body Works' Surge: A Cautionary Tale of Market Optimism Bath & Body Works, a personal care products retailer, has earned a "Buy" rating from Citi analysts led by Paul Lejuez.
The upgrade and associated $25 price target have driven shares to new heights, leaving investors wondering if this is more than just market enthusiasm.
The company's fortunes are closely tied to Wall Street analyst projections for future earnings.